Literature DB >> 25201017

Lower extremity peak force and gait kinematics in individuals with inclusion body myositis.

Todd E Davenport1, Kimberly Benson, Stephanie Baker, Christopher Gracey, Goran Rakocevic, Beverly McElroy, Marinos Dalakas, Joseph A Shrader, Michael O Harris-Love.   

Abstract

OBJECTIVE: To determine the relationship between peak isometric muscle force and temporal characteristics of gait in individuals with sporadic inclusion body myositis (s-IBM).
METHODS: An observational study of 42 individuals with s-IBM (12 women; mean ± SD age 61.8 ± 7.3 years and mean ± SD disease duration 8.9 ± 4.3 years) was conducted at a federal hospital. Peak isometric force measurements for lower extremity (LE) muscle groups were obtained using quantitative muscle testing. Temporal characteristics of gait during habitual and fast walking conditions were measured using a portable gait analysis system.
RESULTS: All observed muscle force values were significantly lower than predicted values (P ≤ 0.001). During habitual walking, the subjects' gait speed and cadence were ≤83% of normative literature values. During fast walking, total gait cycle time was 133% of normal, while gait speed and cadence were 58% and 78% of normative literature values, respectively. Scaled LE peak muscle forces showed significant moderate correlations with temporal gait variables. Weaker subjects had greater limitations in gait speed and cadence compared with stronger subjects (P < 0.05). Peak isometric force of the knee flexors and ankle plantar flexors was significantly correlated with most temporal features of habitual gait.
CONCLUSION: Muscle weakness associated with s-IBM disease activity may contribute to diminished gait kinematics. Temporal features of gait were not substantially influenced by knee extensor weakness alone, considering the knee flexors and ankle plantar flexors played a compensatory role in maintaining the walking ability of individuals with s-IBM.
Copyright © 2015 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2015        PMID: 25201017      PMCID: PMC4458849          DOI: 10.1002/acr.22468

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  36 in total

1.  Stride-dependent changes in gait of older people.

Authors:  R J Elble; S S Thomas; C Higgins; J Colliver
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

Review 2.  Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.

Authors:  Marinos C Dalakas
Journal:  Nat Clin Pract Neurol       Date:  2006-08

Review 3.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

4.  Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation".

Authors:  Marinos C Dalakas
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

5.  Age-related changes in speed of walking.

Authors:  J E Himann; D A Cunningham; P A Rechnitzer; D H Paterson
Journal:  Med Sci Sports Exerc       Date:  1988-04       Impact factor: 5.411

6.  The relationship of lower extremity strength and gait parameters in patients with post-polio syndrome.

Authors:  J Perry; S J Mulroy; S E Renwick
Journal:  Arch Phys Med Rehabil       Date:  1993-02       Impact factor: 3.966

7.  Factors affecting walking speed of elderly people.

Authors:  M J Bendall; E J Bassey; M B Pearson
Journal:  Age Ageing       Date:  1989-09       Impact factor: 10.668

8.  Factors affecting the heart rate during self-paced walking.

Authors:  E J Bassey; I A Macdonald; J M Patrick
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1982

9.  Inclusion body myositis: its relative frequency in elderly people.

Authors:  M L Maat-Schieman; J D Macfarlane; G T Bots; A R Wintzen
Journal:  Clin Neurol Neurosurg       Date:  1992       Impact factor: 1.876

10.  Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials.

Authors:  A Cortese; P Machado; J Morrow; L Dewar; A Hiscock; A Miller; S Brady; D Hilton-Jones; M Parton; M G Hanna
Journal:  Neuromuscul Disord       Date:  2013-03-11       Impact factor: 4.296

View more
  2 in total

1.  The Influence of Upper and Lower Extremity Strength on Performance-Based Sarcopenia Assessment Tests.

Authors:  Michael O Harris-Love; Kimberly Benson; Erin Leasure; Bernadette Adams; Valerie McIntosh
Journal:  J Funct Morphol Kinesiol       Date:  2018-11-03

2.  Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods - a qualitative study.

Authors:  Alexander Oldroyd; William Dixon; Hector Chinoy; Kelly Howells
Journal:  BMC Rheumatol       Date:  2020-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.